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ABSTRACT
Fanconi Anaemia (FA) is a cancer predisposition
disorder characterized by spontaneous chromo-
some breakage and high cellular sensitivity to
genotoxic agents. In response to DNA damage, a
multi-subunit assembly of FA proteins, the FA core
complex, monoubiquitinates the downstream
FANCD2 protein. The FANCE protein plays an
essential role in the FA process of DNA repair as
the FANCD2-binding component of the FA core
complex. Here we report a crystallographic
and biological study of human FANCE. The first
structure of a FA protein reveals the presence of a
repeated helical motif that provides a template for
the structural rationalization of other proteins
defective in Fanconi Anaemia. The portion of
FANCE defined by our crystallographic analysis is
sufficient for interaction with FANCD2, yielding
structural information into the mode of FANCD2
recruitment to the FA core complex. Disease-
associated mutations disrupt the FANCE–FANCD2
interaction, providing structural insight into the
molecular mechanisms of FA pathogenesis.
INTRODUCTION
A group of rare genetic conditions collectively deﬁned as
chromosome instability syndromes has received much
attention in recent years, as their study continues to
provide important insight into the molecular mechanisms
responsible for the integrity of our genome. One
such condition is Fanconi Anaemia (FA), a genetically
heterogeneous disorder characterized by congenital
abnormalities, aplastic anaemia and predisposition to
cancer, especially acute myeloid leukemia and squamous
cell carcinomas (1–3). A conspicuous cellular feature of
FA is chromosomal fragility and hypersensitivity to DNA
cross-linking agents such as mitomycin C, diepoxybutane
and cisplatin. Sensitivity to genotoxic agents suggests that
the pathogenic eﬀects of FA are due to defects in the
molecular mechanisms of DNA damage signalling and
repair (4–6).
Twelve diﬀerent FA subtypes (A, B, C, D1, D2, E, F,
G, I, J, L, M) have been isolated, and the genes for all but
type I have been cloned (7). The majority of FA proteins
do not possess clear functional motifs, and only a subset
of them have been associated with an enzymatic activity,
including a E3 ubiquitin ligase, FANCL (8,9), and two
helicases, FANCJ (10,11) and FANCM (12,13). A nuclear
multi-subunit complex of at least eight FA proteins
(FANCA, FANCB, FANCC, FANCE, FANCF,
FANCG, FANCL and FANCM), the FA core complex
(14), adds a single ubiquitin chain to FANCD2 following
DNA damage or replicative stress (15) (Figure 1A).
Monoubiquitination acts as a signal for FANCD2
recruitment to nuclear foci where it colocalizes with
cell-cycle checkpoint regulation and DNA repair proteins
such as BRCA1, BRCA2 and RAD51 (15–17). Within the
FA core complex, individual constituents engage in
multiple interactions with each other, giving rise to
functional subcomplexes (18,19). Recent evidence also
points to additional roles of the FA core complex besides
FANCD2 ubiquitination (20). Although much has been
learned about the role of the FA proteins in maintenance
of genome stability, our understanding of the molecular
mechanisms underlying their function remains largely
incomplete.
FANCE is essential for FANCC accumulation in the
nucleus and assembly of the FA core complex (21,22).
Moreover, FANCE localizes to constitutive nuclear foci
(21) and becomes associated with ubiquitinated FANCD2
and BRCA2 in a chromatin complex (23). FANCE is the
only member of the FA core complex for which a direct
association with FANCD2 has been demonstrated (21).
Indeed, it has been proposed that FANCE represents the
essential link between the FA core complex and FANCD2
(19,21,22).
Here we describe the identiﬁcation and crystallographic
analysis of a large, evolutionarily conserved region of
human FANCE. The ﬁrst structure of a FA protein
reveals the presence of a repeated helical motif, which was
not apparent from the analysis of its amino acid sequence
and represents a structural template for other proteins
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FANCE region deﬁned by the structure is suﬃcient for
interaction with FANCD2 and identify an epitope on the
FANCE surface that is critical for FANCD2 binding.
Disease-associated mutations in FANCE and FANCD2
disrupt the FANCE–FANCD2 interaction, providing a
structural rationale for their pathological eﬀect in FA
patients.
MATERIALS AND METHODS
Purification and crystallization
A C-terminal segment of the human FANCE protein
spanning amino acids 273 to 536 (natural C-end) was
cloned into the pET28a plasmid vector and over-expressed
in the E. coli BL21(DE3) strain as a 6xHis-tagged protein.
The recombinant protein was puriﬁed by standard Ni
2þ-
aﬃnity chromatography over a HisSelect
TM Sepharose
(Sigma, UK) column. The histidine tag was cleaved with
thrombin protease and the digested sample was passed
again over the HisSelect column in order to remove the
cleaved tag. The FANCE protein was further puriﬁed by
size exclusion chromatography using a Superdex
TM 16/60
Global 200 column (GE Healthcare, UK).
Mutagenesis was performed with the Quick Change
TM
II mutagenesis kit according to the manufacturer’s
instruction (Stratagene). The C391A FANCE mutant
used for structure determination was puriﬁed like the wild-
type protein, and crystallized by vapor diﬀusion against
buﬀer solution 22 of the Crystal Screen Cryo (Hampton
Research, USA), consisting of 0.085M Tris pH 8.0,
0.170M sodium acetate, 25.5% w/v PEG 4000, 15%
glycerol.
Phasing andrefinement
The X-ray crystal structure of FANCE was solved using
the anomalous signal of the selenomethionine-substituted
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Figure 1. Structure of human FANCE. (A) In response to DNA damage or replicative stress, the FA core complex monoubiquitinates FANCD2.
The eight identiﬁed subunits of the FA complex are shown. (B) Schematic representation of the domain structure of the FANCE protein.
Orange boxes represent regions of the protein that are predicted to constitute independently folded domains. The two nuclear localization sequences
in the middle section of the protein are drawn in black. (C) Cartoon representation of the crystal structure of amino acids 273 to 536 of human
FANCE. The protein chain is shown as a ribbon, rainbow-coloured from blue at the N-terminal end to red at the C-terminal end. Two views are
shown, diﬀering by a 908 rotation around an axis aligned to the long dimension of the molecule. The alpha-helical segments in the structure are
labelled, a1t oa14. The positions of the ﬁve helical repeats identiﬁed in FANCE are indicated next to the structure.
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and multiple anomalous dispersion data to 2.8A ˚ were
collected at beamline ID29 of the European Synchrotron
Radiation Facility (ESRF), Grenoble, France. The
diﬀraction intensities were measured in MOSFLM (24)
and merged in SCALA (25). The positions of the selenium
atoms in the asymmetric unit were determined in Shake-
and-Bake (26), and used as input for phasing in SHARP
(27). The solvent-modiﬁed map calculated by SHARP was
readily interpreted by ARP/wARP (28), which produced
an almost complete model of the structure. Reﬁnement of
the structure was carried out in REFMAC5 (29), together
with minor manual rebuilding in COOT (30). The ﬁnal
crystallographic model comprises 249 amino acids and
223 water molecules (2067 atoms), and includes amino
acids 275 to 535 of the human FANCE sequence.
Residues 301 to 307 in the loop linking helix 1 and helix
2, and residues 479 to 483 in the intra-helical loop of
repeat FANC4 are not visible in the electron density
map and are not included in the ﬁnal model.
The conformation of amino acids 484, 485 and 518 to
521 in the inter-helical loops of repeats FANC4 and
FANC5 must be considered tentative as the quality of the
electron density is poor for these residues. 97.3% of
residues in the crystallographic model are in the most
favoured regions of the Ramachandran plot, 2.7% in the
allowed regions and none in disallowed regions of the plot.
Figures were prepared with PyMOL (http://
pymol.sourceforge.net).
Yeasttwo-hybrid analysis
The MATCHMAKER Two-Hybrid System 3 (Clontech)
was used for yeast two-hybrid analysis according to the
manufacturer’s instructions and as described earlier (31).
Brieﬂy, GAL4-activation domain and GAL4-binding
domain constructs were either sequentially transformed
into AH109 yeast cells and subjected to selection on -trp/-
leu/-his/-ade medium, or transformed separately into
AH109 and Y187 yeast strains and mating cultures
plated onto selection medium. Transformations were
performed using a PEG/ssDNA/lithium acetate proce-
dure. Colonies that grew on -trp/-leu/-his/-ade selection
media were transferred onto ﬁlters and tested for
b-galactosidase expression with X-gal. The activation of
the three reporters in this system: His3, Ade2 and LacZ,
was assayed for in each single experiment. Yeast colony
growth therefore represents simultaneous activation of the
His3 and Ade2 reporters and blue colouring of colonies
following X-gal treatment represents activation of the
LacZ reporter. Experiments were performed at least in
triplicate.
RESULTS
Domain mappingand structural analysis of FANCE
The human FANCE gene encodes a protein of 536 amino
acids. Examination of its sequence in DISOPRED (32)
reveals the presence of a disordered region between
residues 170 and 270, linking N- and C-terminal domains
with high predicted secondary structure content
(Figure 1B). In addition, amino acids in the C-terminal
domain display a higher degree of evolutionary conserva-
tion relative to the rest of the protein (Figure 2).
Thus, FANCE sequence analysis suggests that its
C-terminal region might represent a distinct protein
domain capable of autonomous folding and suitable for
biophysical investigation. We expressed and puriﬁed a
region of human FANCE spanning residues 273 to 536
(264 amino acids). Initial crystallization experiments were
unsuccessful. SDS-PAGE analysis showed a marked
tendency of the recombinant protein to multimerize
through disulphide-mediated cross-linking. Systematic
replacement of cysteine residues with alanine showed
that the C391A mutation removed the tendency of the
protein to form covalent aggregates (Supplementary
Figure 1) and promoted the growth of crystals suitable
for high-resolution X-ray analysis. The crystal structure
was solved to a resolution of 2.0A ˚ by the multiple
anomalous dispersion method using selenomethionine-
substituted protein (Table 1). In the rest of the article, we
will refer to the FANCE region studied here simply as
FANCE.
General features ofthe structure
The crystal structure reveals that FANCE consists
predominantly of helices (thirteen a-helices, one
310-helix) and no b-strand (Figure 1C). The molecule
adopts an elongated, non-globular shape, with a size of
70A ˚ in its longest dimension, a width of 30A ˚ and
thickness of 20A ˚ . The polypeptide folds in a continuous,
right-handed solenoidal pattern from the N- to the
C-terminal end of the chain. Beginning with helix a5,
the loops of the solenoid become more regular, and it is
possible to identify ﬁve copies of a helical motif repeating
to the C-end of the protein. Thus, the most outstanding
feature of the FANCE structure is the presence of a
repeated motif, which was not detected by the inspection
of the amino acid sequence.
The repeats vary between 30 and 40 amino acids in
length and fold in an antiparallel helical hairpin (Figures 2
and 3). The two helices (H1 and H2) of the repeat are of
similar size, spanning between three and four turns, and
cross with an angle varying between 218 and 358. The
helices in the repeat are straight or display only a minimal
degree of bending. The only exception to these character-
istics is seen in helix H1 of repeat 1, which is longer at ﬁve
turns and shows a pronounced kink between the
second and third helical turn. In each repeat, helices
H1 and H2 make extensive contacts with each other and
with the helices of neighbouring repeats, thus generating a
continuous hydrophobic core extending throughout the
molecule. The loops connecting the helices within a repeat,
as well as adjacent repeats, vary signiﬁcantly in length and
conformation.
Each repeat lies within an ideal plane that is broadly
perpendicular to the long axis of the molecule, and
stacking of the repeats in a consecutive array generates a
double layer of helices. Within the structure, adjacent
repeats are related by a rotation and a tilt along an
axis parallel to the long dimension of the structure,
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The rotation angle between repeats 1 and 2 and repeats
3 and 4 spans  358, whilst the rotation angle between
repeats 2 and 3 and 4 and 5 is  158. The presence of
super-helical curvature does not confer an overall curved
shape to the structure, since the direction of rotation
changes as one moves from the N- to the C-terminus of
the chain: repeats 2 and 3 show a left-handed rotation,
Mouse   1 MVPGQRPTEEKQRPGEHWRESGAFCEKKIRMLQPPPRVRSALATPGSDSVASAGAAPWAS
Human   1 ------------------------------MATP------DAGLPGAEGVEPA---PWAQ
Chicken   1 ------------------------------------------------------------
Zebrafish   1 ---------------------------------------------------MDRTALLQR
Mouse  61 LEAPARLLLQALQAGPEGARRGLGVLRALG-RRAEHFPWDGFLEALGHLEPEVRGPDGRL
Human  22 LEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRL
Chicken   1 ---------MGLWLCESAAIPKLGAQWEVG-----------------------------C
Zebrafish  10 FDARSRLLVHALHLGAEGARKAQMVFNKQR-KCDPHFSLTPFLESLCQQEACLH--EDAL
Mouse 120 ELVPLLLRLPGVCQKNLLSLLLALLPSLPESGLRSVLQLHHQDVSSTTDAWLHALGELLR
Human  82 ELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLR
Chicken  23 ISKPRLLLLPVLCQRNLFSLLHAVAAVVPTDCLRQLLTAAGQDPQPDP--WVHALGVLLL
Zebrafish  67 VLKPLACVFSDVFKQNLLCFLHLIHPGYPKDSVLHLLQCLSEEDGGNQ--WASALITQLK
Mouse 180 RDVGVG-VAEGSSPLTRSCQLQLRDLCGRLGQGGR--GLKLALAPDPEQED-RLSQLCGK
Human 142 RDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGR--RLKSPQAPDPEEEENRDSQQPGK
Chicken  81 RGEER--SSPPPPPLTASGQQQLKCLCQKIAQSKAEGRRKLKWCFSKQDGDAAGCVLPGG
Zebrafish 125 RDVEG---ARKGTLLSSNCTETLKSLCGRFRDTDVQGGWTSCFEALEAKGEETDMSVLCQ
Mouse 236 RTKEPEE-AASPESERSPKRFRGCEEAVEGKEPEERPTLESLGSPPDAGGVLPDTD----
Human 200 RRKDSEEEAASPEGKRVPKRLR-CWEEEEDHE-KERPEHKSLESLADGGSASPIKDQPVM
Chicken 139 KRKKVLEESLEFSEEREGKRPLLEDAVFELQGGLDGTAGVGEEVPGETSGDGSAQSLAGA
Zebrafish 182 KKRKSDKLDLDGDAQKDPQ---------------SKKVKMDFSSSKDEEGMIEEEEAEIR
Mouse 291 -AQAPETGPGVEGP--KGPAESVELPKVVQDQVPRLQLLLKAFQEGLEGQE-KPLVDLQF
Human 258 AVKTGEDGSNLDDA--KGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQL
Chicken 199 ALESPQQNADKEPSRISRPEVAVEVQSFIQMHGPRLKMLLLQEASHAEP---SIPPELHI
Zebrafish 227 RSQMDQSAGSVSQARSDLLGSSKNLPDHMKAALPVIKELLDAESEWDD----SSVSALKV
Mouse 347 LHECSPSEMELLCSELQLPQLPDGGLLQLCSHLMGLTPALSLSNASVLARSLFLDRIRSL
Human 316 LHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSL
Chicken 256 LNSCSPSQLEGLCSFLQLSTCPEQLLGRFCSWLLALTPDLSYTSAAVLAEQLFLTRVLSL
Zebrafish 283 LHECDPNEVEVLCSVLCLSEVSEQCLPQFCSCLLKLAPDLSHSTASALITHLLLKKILSL
Mouse 407 PSSASRLLRVALVSFCVKYTYAICRAVLCPLLQDPRVGPAQTELLCSLIKDESLESDMQV
Human 376 TSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQV
Chicken 316 SQPPSRHLMAALISFCSKYSEPFCQVLVAPVLREPGQGAEQTKLVCELV-EECLEPDYVR
Zebrafish 343 AEPASRCLVTAVTSLCSRYPRPTCQALIEPLLQKGQLGSAQADLLCRLVID-CLEPHHRL
Mouse 467 QILGQVLELAWREETFLVLQTLLERQVEMTPEVFSVLVQRLCKEGPAATTSMAYAKLMLT
Human 436 LMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLT
Chicken 375 MVLGQVLAVPLTEKLLPVVLAVLGRQEPLPSELFDLLVLTLCRQAPAFATSLSYAKLVTA
Zebrafish 402 LVFRTALGASWDEGVLSVIHALLDSKLELSQEDFCLFAEHLCSQSPHFSKSMKFAKMLLS
Mouse 527 VMTKYQTSITEQQSLDLAVALEPNATFLKKALQAALRHVTH
Human 496 VMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP
Chicken 435 VLTTYSSQLSPSHRSRLAAALDGSNAALRRSLQAALGR---
Zebrafish 462 VLTKYQSNVNPACHHTLSSVLSFNETFLKKSLQAALKRISF
* *
*
H1-1
H2-1 H1-2 H2-2
H3-1 H3-2 H4-1 H4-2
H5-1 H5-2 * * *
*
Figure 2. Multiple sequence alignment of FANCE orthologues. The amino acid sequences of mouse, human, chicken and zebraﬁsh FANCE were
aligned in the program ClustalW. Absolutely conserved residues are highlighted in green, identical residues in yellow and conserved residues in cyan.
The secondary structure elements identiﬁed in the FANCE structure are marked above the alignment. FANCE residues involved in FANCD2
binding by bioinformatic and yeast two-hybrid analysis are marked by an asterisk below the alignment. Residues mutated in Fanconi Anemia are
highlighted by a red box.
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Because of the reversal in the sense of rotation the helices
in repeat 5 become parallel again with those of repeat 1.
The FANC repeat
The repeated motif identiﬁed in the structure of human
FANCE represents a novel member of the large family
of two- and three-helical motifs that includes the well-
characterized HEAT and ARM repeats (33). Here we will
refer to the helical motif in human FANCE as the FANC
repeat. Although the ﬁve FANC repeats clearly share the
same architecture, their pairwise superposition gives a
root mean square deviation (rmsd) varying between 1.4
and 2.7A ˚ over 24 alpha carbon positions, thus pointing
Table 1. X-ray diﬀraction data and reﬁnement statistics
Se-Met Native
Data collection
a
Space group P41212
Cell dimensions (A ˚ ):
a 59.3
b 59.3
c 140.2
Peak Remote Inﬂection
Energy (keV) 12.6609 12.700 12.6590 12.6588
Resolution (A ˚ ) 2.8 2.8 2.8 2.0
Rsym (%) 5.8 (26.8) 6.8 (47.4) 9.9 (88.0) 5.0 (19.5)
Multiplicity 12.9 (13.8) 13.0 (13.8) 13.0 (13.8) 8.6 (8.9)
I/I 10.0 (2.8) 9.2 (1.6) 6.8 (0.9) 8.1 (3.9)
Completeness (%) 98.3 (98.3) 98.6 (98.3) 98.4 (98.6) 98.9 (98.7)
Reﬁnement
Resolution (A ˚ ) 2.0
No. of reﬂections 17665
Rwork/Rfree 0.194/0.244
No. non-H atoms 2067
Mean B value (A ˚ 2) 32.9
Matthews coeﬃcient 2.13
Solvent content (%) 41.8
R.m.s deviations
Bond lengths (A ˚ ) 0.018
Bond angles (8) 1.7
aHighest resolution shell is shown in parenthesis.
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 LSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKY
TYPVCSALLDPVLQAPGTG......PAQTELLCCLVKMESLE
 PDAQVLMLGQILELPWK.......EETFLVLQSLLERQVEMT
 PEKFSVLMEKLCKKGLAATTS...MAYAKLMLTVMTKYQANIT
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Figure 3. The FANC repeat. (A) Superposition of the ﬁve copies of the repeated helical motif revealed by the crystal structure. Each repeat is drawn
as narrow tube, with the two helical segments coloured in blue. (B) Structure-based sequence alignment of the ﬁve FANC repeats. Conserved
hydrophobic residues are highlighted in green. Amino acids that become buried at the intra- and inter-repeat interfaces are boxed. Two sets of three
asterisks below the alignment indicate the two triplets of hydrophobic residues that interact in a similar fashion within a repeat. (C) Example of intra-
repeat packing of hydrophobic side chains at conserved triplet positions in the FANC3 repeat. The trajectory of the main chain atoms of the repeat
is indicated by a narrow tube, whereas the two triplets of interacting side chains are drawn as sticks, coloured in two hues of green.
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The three C-terminal repeats are structurally closer to
each other, whereas the ﬁrst and second FANC repeats
are more divergent.
A structure-based alignment of the ﬁve repeats of
human FANCE shows that no amino acid is absolutely
conserved across repeats (Figure 3B). However,
eight speciﬁc positions in the FANC repeat show a
strong preference for hydrophobic residues with aliphatic
side chains, prevalently leucine but also valine, isoleucine
and methionine. No signiﬁcant conservation of any other
residue is observed in the repeat. In keeping with the
symmetric architecture of the repeat, the eight conserved
positions are distributed equally between the two helical
segments. Thus, each helix contains two hydrophobic
dipeptides spaced one turn apart, located in the third and
fourth turn of helix H1 and in the second and third turn of
helix H2, respectively. The only non-hydrophobic residues
within the eight conserved positions are Thr364 in
FANC1, which is buried at the interface between
FANC1 and FANC2, and solvent-exposed Glu517,
Lys528 and Lys532 in FANC5.
The FANCE structure provides a rationale for the
observed pattern of amino acid conservation in the FANC
repeat: residues at conserved positions contribute
the majority of side chains concurring to form the
hydrophobic core of the protein. Conservation of amino
acids at speciﬁc positions across repeats reﬂects the
structural conservation in the mode of packing of the
two antiparallel helices in a repeat. Thus, within each
repeat it is possible to identify two triplets of amino acids,
at positions 8, 9, 35 and positions 12, 31, 32, respectively,
that make equivalent hydrophobic contacts (Figure 3B).
The side chain at position 12 in H1 is inserted between the
side chains at positions 31, 32 in H2, whilst the side
chain at position 35 in H2 interdigitates in a similar
fashion with side chains at positions 8, 9 in H1
(Figure 3C). In the case of the longer FANC1 repeat, an
additional triplet is formed by Arg371 and Ile372 in helix
H1 and Leu383 in helix H2. Hydrophobic positions 13 in
helix H1 and 36 in helix H2 are not involved in triplet-like
interactions and engage in inter-repeat contacts with
the same helix of the proximal, C-terminal repeat.
The conserved hydrophobic side chains further intermesh
across neighbouring repeats, giving rise to the compact
and uninterrupted hydrophobic core of the molecule.
The core of the FANCE structure is completed by
aromatic or hydrophobic residues, two or three per
repeat, situated in the loops between the helices, that
bury their side chains inside the protein.
No other position maintains a signiﬁcant degree of
conservation among FANC repeats. However, fourteen
residues outside the eight conserved hydrophobic
positions are invariant between human and zebraﬁsh
FANCE (Figure 2). Of these, eleven are situated within
or near intra- and inter-repeat loops, and their
conservation is explained by their involvement in direct
or water-mediated polar contacts that are important for
maintaining the conformation of the polypeptide
chain. Thus, Tyr394, Gln416 and Tyr500 provide
sidechain-to-mainchain hydrogen bonds that bridge
between adjacent repeats, whilst serine residues 356, 380
and 486 act as N-terminal helical caps. Three of the four
conserved proline residues are part of a short tetrapeptide
sequence of consensus PxL(S/Q) that occurs six times in
the structure, spanning inter-helical loops or at the
extremities of helical segments.
Similarity toother structures
Our crystallographic analysis reveals that FANCE
belongs to the large family of non-globular protein
structures assembled by tandem repetition of helical
motifs. Fold-recognition analysis in DALI (34) shows
that FANCE is structurally similar to HEAT- and ARM-
repeat proteins such as importin-b (35), b-catenin (36), the
Cand1 protein (37) and the PR65/A subunit of protein
phosphatase 2A (38). Indeed, comparative structural
analysis reveals that the FANC repeat shares four of the
seven conserved positions that form the hydrophobic core
in the HEAT and ARM repeats (33) (Figure 4). Residues 8
and 12 in helix H1 of the FANC repeat coincide with
residues 13 and 17 in helix A of the HEAT repeat
(helix H2 of the ARM repeat); residues 31 and 35 in helix
H2 of the FANC repeat correspond to residues 28 and 32
in helix B of the HEAT repeat (helix H3 of the ARM
repeat).
The FANC repeat diﬀers from well-characterized
helical motifs such as the HEAT and ARM repeats in
some important ways. The most evident feature is the
Figure 4. Comparison of HEAT, ARM and FANC repeats.
(A) Diﬀerent conformations adopted by the HEAT, ARM and
FANC repeats. The helices in the diﬀerent repeats are drawn in red,
as narrow ribbons, and are labelled as A, B (HEAT); H1, H2 and H3
(ARM); H1 and H2 (FANC). The pronounced kink in helix A of the
HEAT repeat becomes two diﬀerent helices (H1 and H2) in the ARM
repeat. The HEAT and ARM repeats shown in the ﬁgure are
repeats 10 and 2 of PDB entries 1b3u and 3bct, respectively.
(B) Structure-based alignment of consensus sequences for HEAT,
ARM and FANC repeats. The helices in the alignment are labelled
A and B, following the convention adopted for the HEAT repeat. The
numbering below the alignment refers to the HEAT and ARM repeat
sequences. Hydrophobic residues are in green, acidic residues in red,
basic residues in blue and other residues in cyan. Positions in the
FANC repeat marked by a small ‘h’ have a general preference for
hydrophobic residues. Four positions where the chemical nature of the
amino acid is conserved across the three repeat types are boxed.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1643absence of conserved positions beyond the selection of
hydrophobic amino acids that become buried at the intra-
and inter-repeat interfaces. In the helical regions of the
repeat, no conservation of structural amino acids, such as
proline at position 11 in the ﬁrst helix of the HEAT
and ARM repeats or glycine at position 8 of the ARM
repeat, is observed. A lack of conserved prolines or
glycines at speciﬁc positions means that both helices in
the FANC repeat are straight or minimally bent, at
variance with the kinked ﬁrst helix of the HEAT repeat,
which becomes two diﬀerent helical segments in the
ARM repeat. Likewise, no conservation of inter-repeat
contacts is present, such as the interaction between the
aspartic acid in position 19 of the inter-helical loop of the
HEAT repeat and arginine at position 25 of the next
repeat (33).
Functional implications forother FA proteins
A virtually complete complement of FA proteins can be
traced back in evolution to the last common ancestor
of vertebrate organisms,  450 million years ago (39).
Probing further down the evolutionary tree of individual
FA proteins reveals that conservation is limited to
the FANCD2 and FANCL proteins (40). Thus, the
components of the FA core complex seem to have arisen
in order to introduce an additional level of complexity
to a primitive FA network of DNA repair. No structural
information is presently available about the three-
dimensional architecture of the FA core complex,
or indeed any of its constituent proteins.
Interestingly, a majority of components of the FA
core complex (FANCA, FANCB, FANCC, FANCE,
FANCG and FANCF), as well as FANCD2, share
an unusually high content of leucine residues
(Supplementary Table 1), ranging from 12.1% for
FANCB to 19.5% for FANCG, above the average leucine
frequency in vertebrate proteins (less than 10%).
Furthermore, their predicted content of secondary
structure is high, which suggests that the FA proteins
of the core complex are independently folded and do not
rely on the structural environment provided by the
complex for their tertiary structure. An abundance of
aliphatic residues, and of leucines in particular, is an
essential requirement in order to achieve the kind of
packing observed in the hydrophobic core of non-
globular, helical repeat proteins. For instance, the leucine
content of the protein phosphatase 2A PR65/A subunit
and b-catenin is 13.8 and 14.7%, respectively. It is
therefore likely that, as shown here for FANCE,
other leucine-rich FA proteins adopt a non-globular fold
based on arrays of a repeated helical motif. Indeed, seven
tetratrico peptide repeats, short helical motifs that are
structurally related to the HEAT and ARM repeats, have
been convincingly located in the FANCG sequence (41).
Based on the FANCE structure, we predict that, in
addition to FANCE, leucine-rich FA proteins FANCA,
FANCB, FANCC, FANCF and FANCD2 fold partially
or entirely in solenoidal structures constituted by arrays of
FANC-like repeats.
Interaction withFANCD2
Recruitment of FANCD2 to the FA core complex is
essential for its monoubiquitination after DNA damage.
Evidence of a direct interaction between FANCD2 and
FANCE in vitro and in vivo has led to the proposal that
FANCE represents a physical link between FANCD2
and the FA core complex (21,22). Consequently, we
decided to investigate whether the FANCE structure
described here included the FANCD2-binding domain.
Yeast two-hybrid analysis revealed that a region of
FANCE spanning amino acids 273 to 536, coinciding
with the recombinant FANCE protein prepared for
structural analysis, interacted strongly with full-length
FANCD2 (Figure 5). The C391A mutant used for
structure determination retained wild-type aﬃnity for
FANCD2 in the assay. Thus, the result of the structure-
based yeast two-hybrid analysis recapitulates and reﬁnes
previous ﬁndings concerning the FANCE–FANCD2
interaction, by deﬁning the structural domain of
FANCE that is suﬃcient for FANCD2 binding. It has
also been reported that the interaction with FANCE was
mediated by N-terminal region of FANCD2 (42).
In agreement with such ﬁndings, we found that two
N-terminal truncations FANCD21102 and FANCD2712,
to amino acids 1102 and 712 respectively, maintained
FANCE binding in the yeast two-hybrid assay (Figure 5).
Previous experiments have also demonstrated a strong
interaction of FANCE with FANCC, another essential
component of the FA core complex, and the existence of a
ternary FANCC–FANCE–FANCD2 complex has been
postulated (19,22). In contrast to the interaction with
FANCD2, binding to FANCC was attributed to a central
region of FANCE spanning its two NLS sites.
In agreement with these observations, the yeast two-
hybrid analysis showed that FANCE residues 273 to 536
did not interact with FANCC (Figure 5). Thus, our data
support previous reports that diﬀerent regions of
FANCE are responsible for interacting with FANCC
and FANCD2.
In order to identify the site of interaction with
FANCD2, we performed an in silico analysis of the
FANCE structure using the optimal docking area (ODA)
method (43). Brieﬂy, ODA searches for continuous
patches on the surface of a protein with a favourable
desolvation energy when buried, as is the case at a
protein–protein interface. ODA analysis identiﬁed a set of
contiguous residues with favourable desolvation energies
centred around Phe522, in the exposed intra-helical
loop of repeat FANC5 (Figure 6). Analysis of the ODA
epitope reveals that Phe522 is part of a cluster of
conserved, hydrophobic residues that includes Met487
and Leu523, which in turn is surrounded by hydrophilic
residues Glu448, Ser486 and Lys491. The presence of a
hydrophobic centre contoured by polar amino acids
poised to make charged interactions is in agreement
with known interface features of non-obligate protein
complexes. In support of their potential functional role,
residues Glu448, Ser486 and Lys491 are conserved
between human and zebraﬁsh FANCE.
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on the FANCE surface was veriﬁed experimentally.
To this purpose, we designed a double FANCE mutant,
where the chemical nature of the solvent-exposed
hydrophobic residues Phe522 and Leu523 had been
reversed by mutation to the hydrophilic glutamic acid.
If the surface patch identiﬁed by the ODA analysis is part
of the interface in the FANCE–FANCD2 complex,
the presence of unpaired charges in the hydrophobic
environment of the interface would disrupt or signiﬁcantly
impair the ability of the two proteins to interact.
Circular dichroism spectroscopy and gel ﬁltration chro-
matography experiments conﬁrmed that the mutant
FL522-523EE protein retained the native conformation
of wild-type FANCE (Supplementary Figure 2). Yeast
two-hybrid analysis showed that the simultaneous muta-
tion of Phe522 and Leu523 to glutamic acid abolished
the interaction between FANCE and FANCD2.
The identiﬁcation of a single putative protein–protein
interaction site implies that the primary function of the
C-terminal region of FANCE is to associate with
FANCD2 and does not include multiple, concurrent
interactions. The occurrence of conserved Ser486at the
putative protein–protein interface suggests that the
FANCE–FANCD2 interaction might be regulated by
phosphorylation.
Disease-associated mutations
Several missense mutations leading to amino acid
substitutions have been identiﬁed in the FA genes.
However, the molecular basis for the pathogenic
eﬀect of these mutations is still largely unknown.
Four such mutations have been reported in the human
FANCE sequence: S356G, R365K, R371W, A502T
(Fanconi Anaemia Mutation Database) (Figure 7A).
Mapping the mutations on the structure reveals that
three of the four changes (S356G, R365K, R371W)
disrupt hydrogen-bond interactions between the side
chain of the aﬀected amino acid and neighbouring main-
chain atoms, that are important for maintaining the
conformation of the polypeptide chain. Thus, the struc-
ture predicts that the pathogenic eﬀect of these mutations
FANCE FANCD2
273 536
C391A
R371W
1102
1 1471
R302W
1102
FANCC
712
558 1
GAL4 activation 
domain
GAL4 DNA-binding domain Colony filter lift
FL522-3EE
Figure 5. Structure-based yeast two-hybrid analysis of the FANCE–FANCD2 interaction. The FANCE, FANCD2 and FANCC proteins are drawn
as light blue, green and orange bars, respectively, of correct relative size. For N- or C-terminally truncated proteins, the number of the ﬁrst or
last residue in the construct are indicated. The result of the assay for each pair of constructs tested is shown in the right-hand column by the
b-galactosidase colony ﬁlter lift, visualizing activation of the LacZ reported gene.
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the FANCE protein.
The clearest example of such an eﬀect involves Arg371
in the FANC1 repeat, which is at the centre of a network
of direct or water-mediated hydrogen bonds involving the
main-chain carbonyl groups of leucines 333, 336 in the
loop between helices 3 and 4, and Leu367 of the FANC1
repeat, as well as the side chain of Asp338 (Figure 7B).
Thus, mutation of arginine to tryptophan would cause the
loss of several structural hydrogen bonds, leading to
disruption of local protein conformation and severe
destabilization of the FANCE fold. When tested in the
yeast two-hybrid assay, no interaction was observed
between the R371W FANCE protein and FANCD2
(Figure 5). Thus, our data provide a structural rationale
for the pathological eﬀect of the R371 mutation in
FANCE.
An identical pathogenic mutation, R302W, has also
been reported in FANCD2 (Fanconi Anaemia Mutation
Database). As the mutation occurs in the part of the
FANCD2 sequence responsible for binding FANCE, we
determined whether it would disrupt binding to FANCE
of the large FANCD21102 segment. As observed for the
R371W FANCE mutant, no interaction between FANCE
and R302W FANCD21102 was detected in the yeast two-
hybrid assay (Figure 5). It is possible that the R302W
mutation in FANCD2 acts in a similar way to the
FANCE R371W mutation, by compromising the stability
of the protein structure, and that the observed functional
defect is caused by disruption of the FANCE–FANCD2
interaction.
DISCUSSION
Here we have described the crystal structure of a large,
evolutionarily conserved region of FANCE, an essential
component of the FA pathway of DNA repair. The
structure reveals a non-globular, solenoidal conformation
assembled by tandem repeats of a short helical motif.
Remarkably, FANCE folding requires only general
conservation of amino acid type at a small set of repeat
positions, which makes detection of such a motif diﬃcult
and explains why its presence had not been noted before.
Packing in the hydrophobic core of helical repeat proteins
relies on aliphatic side chains of hydrophobic residues,
such as leucine. The structure of the FANCE protein
therefore provides a rationale for the high leucine content
of its sequence and suggests that other FA proteins rich in
leucines will adopt a comparable fold.
Multiple arrays of short helical motifs have evolved as a
convenient protein architecture in order to mediate
protein–protein association. Indeed, helical repeat pro-
teins are usually involved in constitutive or regulated
interactions as part of binary or multi-subunit complexes;
Phe522
Met487 Lys491
Leu523
Glu448
Ser486
Thr485
A
B
Figure 6. Protein–protein interaction site in the FANCE structure. (A) A bioinformatic analysis of the FANCE structure was performed in order to
identify potential protein–protein interaction sites. The solvent-accessible surface of FANCE is shown in blue and the putative protein–protein
interaction site is marked by a gold circle. The position of amino acids with favourable desolvation energy is indicated in cyan. (B) Close view of the
protein–protein interaction site, showing the position of the side chains identiﬁed by the bioinformatic analysis. The protein chain is drawn as a
ribbon, contained within a semi-transparent representation of the solvent-accessible FANCE surface. The side chains of the relevant amino acids are
shown as sticks.
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subunit ubiquitin ligase complex by the HEAT-repeat
protein Cand1 (37). A tertiary structure based on arrays of
helical repeats, such as that observed in FANCE, would
therefore be well suited to the function of the FA proteins,
which take part in a complex web of constitutive and
regulatory interactions within and outside the FA core
complex.
Our data indicate that the region of FANCE deﬁned by
the crystallographic analysis is suﬃcient for interaction
with FANCD2. Our results therefore provide insight into
the process of FANCD2 association with the FA core
complex, a necessary step in the activation of the FA
pathway of DNA repair. Taken together with the existing
evidence concerning the interaction of FANCE with
FANCC and FANCD2, our ﬁnding of a large soluble
segment of FANCE able of independent binding to
FANCD2, but not to FANCC, suggests a model of
FANCE function. In the model, FANCE would be
anchored to the FA core complex through a constitutive
interaction with FANCC, whereas the C-terminal region
of FANCE identiﬁed here would be free of contacts with
the rest of the core complex and poised to interact with
FANCD2 in a regulated way. Furthermore, our bioinfor-
matic and experimental analysis deﬁnes an epitope on
the FANCE surface that is critical for FANCD2 binding.
In principle, the development of small molecules designed
to disrupt the FANCE–FANCD2 interface could be
useful in tumour therapy based on DNA cross-linking
agents.
In summary, the work described here represents an
important ﬁrst step in the structural rationalization of the
molecular processes involved in FA. Although the
FANCE–FANCD2 interaction is clearly essential, it is
one example of a set of concomitant binary interactions
that result in FANCD2 monoubiquitination. Future
research will investigate the structural basis for the
interactions between FANCE, FANCD2 and the other
components of the FA core complex that are necessary in
order to activate the FA pathway of DNA repair.
NOTE ADDED IN PROOF Whilst our manuscript
was in production, a structural analysis of the human
FANCF protein appeared in print (Kowal, P., Gurtan,
A.M., Stuckert, P., D’Andrea, A.D., and Ellenberger, T.
(2007) Structural determinants of human FANCF protein
that function in the assembly of a DNA damage signalling
complex J. Biol. Chem., 282, 2047-2055). The study shows
that the C-terminal domain of FANCF folds into a
solenoid comprised of repeated helical hairpins, in
agreement with our prediction about the widespread
adoption of this structural motif among Fanconi
Anaemia proteins.
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Supplementary Data is available at NAR Online.
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Figure 7. Disease-associated mutations in the FANCE protein.
(A) The position of pathogenic mutations S356G, R365K and
R371W identiﬁed in the FANCE protein are mapped on the crystal
structure. The helices are depicted as pink cylinders, connected by loops
drawn as narrow tubes. The side chains of the relevant amino acids are
drawn as ball-and-stick models. (B) Close view of the hydrogen-
bonding network involving the side chain of Arg371. The disease-
associated mutation R371W causes loss of hydrogen-bond interactions
with surrounding residues. The protein main chain is drawn as a
ribbon, relevant side chains as sticks and a water molecule as a small
yellow sphere. Hydrogen bonds are depicted as orange dashed lines.
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